4D-ACS trial investigators found that after placement of a drug-coated stent (DCS), the incidence of net adverse clinical ...

The following is a summary of “Delayed ischemic stroke after PED placement for aneurysms: optimal duration of dual ...

Presented at EuroPCR 2025, the results of the 4D-ACS trial show how a shorter antiplatelet regimen after PCI could reduce ...

CA (UPDATED)—Dropping aspirin after 3 months of dual antiplatelet therapy (DAPT) with ticagrelor (Brilinta, AstraZeneca) following PCI among high-risk patients is associated with lower rates of ...

In the TWILIGHT trial, high-risk patients who were event-free and adherent to a ticagrelor-based DAPT for three months ... myocardial infarction or stroke (aHR 2.92, 95% CI 1.82 – 4.67).

Shorter DAPT came out ahead in the study for the composite outcome of all-cause death, MI, definite or probable stent thrombosis, stroke, and major bleeding. “This study provides evidence that ...